Document is current
Any future updates will be listed below
-
Authors
Angie, Tegehall
Sofie, Ingvast
Åsa, Melhus
Oskar, Skog
Olle, Korsgren http://orcid.org/0000-0002-8524-9547
-
Funding
Funding for this research was provided by:
Swedish Medical Research Council
Novo Nordisk Fonden
Stiftelsen Familjen Ernfors Fond
Barndiabetesfonden
Diabetesfonden
Sten A Olssons Stiftelse för Forskning och Kultur
Uppsala University
- License Information
-
More Information
Article History
Received: 12 January 2022
Accepted: 9 March 2022
First Online: 24 April 2022
Conflict of interest
: The authors have nothing to disclose.
: All work involving human tissue were conducted according to principles expressed in the Declaration of Helsinki. The consent to use pancreatic tissue from deceased organ donors for research purposes was obtained verbally from the deceased person’s next of kin by the physician in charge or obtained from an online database and fully documented in accordance with Swedish law and regional standard practices. The study was approved by the Regional Ethics Committee in Uppsala, Sweden (Dnr 2009/043, 2009/371, 2015/444). Animal experiments were approved by the Uppsala Laboratory Animal Ethical Committee (permit number C141/15), on the condition that only dead bacteria were used if the observation period was prolonged compared with the initial study [CitationRef removed].
